Neurociències Clíniques
2017 SGR 1628
![Foto de Neurociències Clíniques](/img/grupo.png)
![Foto de Instituto de Investigación Biomédica de Lleida](/img/noimage_org.png)
Instituto de Investigación Biomédica de Lleida
Lleida, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Investigación Biomédica de Lleida (136)
2024
-
An Insertion Within SIRPβ1 Shows a Dual Effect Over Alzheimer's Disease Cognitive Decline Altering the Microglial Response
Journal of Alzheimer's Disease, Vol. 98, Núm. 2, pp. 601-618
-
Assessment of the Correlation and Diagnostic Accuracy between Cerebrospinal Fluid and Plasma Alzheimer’s Disease Biomarkers: A Comparison of the Lumipulse and Simoa Platforms
International Journal of Molecular Sciences, Vol. 25, Núm. 9
-
Can Glatiramer Acetate Prevent Cognitive Impairment by Modulating Oxidative Stress in Patients with Multiple Sclerosis?
Pharmaceuticals, Vol. 17, Núm. 4
-
Cerebrospinal fluid neutral lipids predict progression from mild cognitive impairment to Alzheimer’s disease
GeroScience, Vol. 46, Núm. 1, pp. 683-696
-
Effects of Vortioxetine on Cognition and Fatigue in Patients with Multiple Sclerosis and Depression: A Case Series Study
CNS & neurological disorders drug targets, Vol. 23, Núm. 3, pp. 395-401
-
Human lifespan and sex-specific patterns of resilience to disease: a retrospective population-wide cohort study
BMC Medicine, Vol. 22, Núm. 1
-
Plasma fibrinogen and risk of vascular recurrence after ischaemic stroke: An individual participant and summary-level data meta-analysis of 11 prospective studies
European Stroke Journal
2023
-
Agreement of cerebrospinal fluid biomarkers and amyloid-PET in a multicenter study
European Archives of Psychiatry and Clinical Neuroscience
-
Breathing cessation events that compose the apnea-hypopnea index are distinctively associated with the adverse outcomes in Alzheimer's disease
Alzheimer's research & therapy, Vol. 15, Núm. 1, pp. 123
-
Cerebrospinal fluid lipidomic fingerprint of obstructive sleep apnoea in Alzheimer's disease
Alzheimer's research & therapy, Vol. 15, Núm. 1, pp. 134
-
Changes in Plasma Neutral and Ether-Linked Lipids Are Associated with The Pathology and Progression of Alzheimer’s Disease
Aging and Disease, Vol. 14, Núm. 5, pp. 1728-1738
-
Clinical complications after a traumatic brain injury and its relation with brain biomarkers
Scientific Reports, Vol. 13, Núm. 1
-
Cumulative tobacco consumption has a dose-dependent effect on atheromatosis burden and improves severe atheromatosis prediction in asymptomatic middle-aged individuals: The ILERVAS study
Atherosclerosis, Vol. 375, pp. 75-83
-
Editorial: The underlying relationship between sleep and neurodegenerative diseases
Frontiers in Neuroscience
-
Erratum: Author Correction: Common variants in Alzheimer's disease and risk stratification by polygenic risk scores (Nature communications (2021) 12 1 (3417))
Nature communications
-
First pass effect in posterior circulation occlusions: Analysis from the CICAT registry
International Journal of Stroke, Vol. 18, Núm. 2, pp. 221-228
-
Genetic Associations between Modifiable Risk Factors and Alzheimer Disease
JAMA Network Open, Vol. 6, Núm. 5
-
Lipidomic Alterations in the Cerebral Cortex and White Matter in Sporadic Alzheimer’s Disease
Aging and Disease, Vol. 14, Núm. 5, pp. 1887-1916
-
Lipidomic signature of stroke recurrence after transient ischemic attack
Scientific Reports, Vol. 13, Núm. 1
-
Lithium management of periodic mood fluctuations in behavioural frontotemporal dementia: a case report
Frontiers in Psychiatry, Vol. 14